Evidence map›Paper›PMID 42177717›Full record

ArticleNeurology and therapy2026

Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) Risk.

Silvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, Marzia Fronza, Pietro Annovazzi, Marta Simone, Antonio Gallo, Agnese Suppiej, Roberta Lanzillo, Sarah Rasia and 27 more

Abstract read
In one paragraph

Article in Neurology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Silvy PilottoDepartment of Neuroscience and Rehabilitation, University of Ferrara, Sant'Anna University Hospital, Via Aldo Moro 8, 44124, Ferrara, Italy. silvy.pilotto@unife.it.ORCID http://orcid.org/0000-0001-7950-0136
Angelo GhezziDepartment of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Stefania Maria BovaChild Neurology Unit, Buzzi Children Hospital, Milan, Italy.
Marzia FronzaDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Pietro AnnovazziNeuroimmunology Unit-Multiple Sclerosis Center, Hospital of Gallarate, ASST Della Valle Olona, Gallarate, Italy.
Marta SimoneChild Neuropsychiatric Unit, Department of Precision and Regenerative Medicine and Jonic Area, University 'Aldo Moro' of Bari, Bari, Italy.
Antonio GalloDepartment of Advanced Medical and Surgical Sciences, and 3T MRI-Center, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Agnese SuppiejPediatric Clinic, University of Ferrara, Ferrara, Italy.
Roberta LanzilloDepartment of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.
Sarah RasiaMultiple Sclerosis Center, ASST - Spedali Civili of Brescia, Montichiari, Brescia, Italy.
Angela BerardinelliChild Neuropsychiatry, IRCCS Mondino Foundation, Pavia, Italy.
Valentina Torri ClericiNeuroimmunology and Neuromuscular Disease Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Lucia MoiolaNeurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Maurizio ViriDepartment of Child Neurology and Psychiatry, AOU Maggiore Della Carità Novara, Novara, Italy.
Stefano SotgiuDivision of Child Neuropsychiatry, University Hospital of Sassari, Sassari, Italy.
Simona MalucchiDepartment of Neurology and Multiple Sclerosis Regional Referral Centre, AOU San Luigi Gonzaga, Orbassano, Turin, Italy.
Alessandra ProttiDepartment of Neuroscience, Niguarda Hospital, Milan, Italy.
Carlotta CanavesePediatric Neurology Unit, Regina Margherita Hospital, Turin, Italy.
Giacomo LusSecond Division of Neurology, Department of Clinical and Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
Luigi M E GrimaldiUniCamillus International University of Health and Medical Sciences, Rome, Italy.
Marta Zaffira ContiDepartment of Neurology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
Giovanna BorrielloMS Center, San Pietro Fatebenefratelli Hospital, Rome, Italy.
Giovanna De LucaMS Centre, Neurology Unit, SS. Annunziata University Hospital, Chieti, Italy.
Valentina TomassiniMS Centre, Neurology Unit, SS. Annunziata University Hospital, Chieti, Italy.
Alberto PrioriLaboratory of Precision Medicine of Neurological Diseases, Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Science, University of Milan, Milan, Italy.
Martina TosiDepartment of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Nicola PomellaDepartment of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Andrea CoronaLaboratory of Precision Medicine of Neurological Diseases, Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Science, University of Milan, Milan, Italy.
Alen ZolloLaboratory of Precision Medicine of Neurological Diseases, Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Science, University of Milan, Milan, Italy.
Maria Pia AmatoDepartment NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
Eleonora CoccoDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Maria TrojanoDepartment of Translational Biomedicine and Neurosciences - DiBraiN, University of Bari "Aldo Moro", Bari, Italy.
Filippo Martinelli-BoneschiLaboratory of Precision Medicine of Neurological Diseases, Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Science, University of Milan, Milan, Italy.
Sandra D'AlfonsoDepartment of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Roberto BergamaschiMS Centre, IRCCS Mondino Foundation, Pavia, Italy.
Maura PugliattiDepartment of Neuroscience and Rehabilitation, University of Ferrara, Sant'Anna University Hospital, Via Aldo Moro 8, 44124, Ferrara, Italy.
and the PEDIGREE Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSun exposure may influence MS susceptibility, but evidence in pediatric-onset MS (PedMS) is limited. We examined whether reduced early-childhood outdoor time (a proxy for lower sun exposure) is associated with PedMS risk.

methodsIn the Italian multicenter PEDIGREE Study, environmental data were collected using the PEQ-IT questionnaire. We enrolled individuals < 18 years with PedMS and disease duration ≤ 5 years and controls without CNS inflammatory disorders. Outdoor time was reported by season and age (0-1, 1-2, 3-5 years); reduced activity was defined as < 60 min/week.

resultsWe included 114 PedMS cases and 121 controls. Cases were 77.2% female; mean (SD) age 16.8 (2.7) years; mean (SD) age at onset 14.2 (2.6) years; median EDSS 1.0 (range 0-4.0). Associations were strongest in winter: reduced outdoor time was associated with higher odds of PedMS in the first year (adjOR 3.02, 95%CI 1.50-6.08), ages 1-2 (adjOR 2.72, 95%CI 1.45-5.09), and ages 3-5 (adjOR 2.66, 95%CI 1.40-5.07). Across ages 0-5, low winter outdoor activity remained strongly associated (adjOR 4.30, 95%CI 1.82-10.17). Other seasons showed weaker but overall significant trends.

conclusionLimited early-childhood outdoor activity may be associated with increased PedMS risk; larger longitudinal studies are needed.

Indexed as

EpidemiologyMultiple sclerosisPediatricsRisk factorsSun exposureTime spent outdoors

Identifiers

PMID42177717
PMCPMC13396100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.